SchaferAutismReport: NIMH Funds Research to Find Best Treatments for Autism, ADHD

[Guest guest]

Tuesday, June 17,

2008 Reader Supported Vol. 12 No. 87p In This Issue: • • RESEARCHNIMH Funds Research to Find Best Treatments for Autism, ADHDSick Hamsters: More Evidence That Thimerosal Harms Infants • • PUBLIC HEALTHStrong Link Between Crime, Lead Exposure In Children Adverse Reaction Measles Outbreak Rekindles Debate About Vaccinations • • • • PEOPLEAutistic Man Missing From Wisconsin Camp Mass. Boy Is Coming Up For Air Price Makes Life Special At Summer- stock And BeyondGrad Meets Own Challenge • COMMENTARYVandervalk: Vaccines - Shots In The Dark? DEADLINEJune 25 For

JulyAutism Events CalendarSubmit listing here free! the Autism Calendartm hereHundreds of Local Autism EventsRESEARCHNIMH Funds Research to Find Best Treatments for Children with Autism and ADHD Symptomstinyurl.com/6anoqj A new NIMH-funded study will help guide the treatment of attention deficit hyperactivity disorder (ADHD) symptoms in children with autism spectrum disorders (ASD). ADHD symptoms are common in children with ASD, but children with ASD often do not respond well to stimulant medications, the conventional treatment for ADHD. In this 10-week clinical trial, Handen, Ph.D., of the University of Pittsburgh; Tristram , Ph.D., of the University of Rochester; and Aman, Ph.D., of the Ohio State University,

and colleagues at the three sites will recruit 144 children ages 5–13 who have ASD with ADHD symptoms. The researchers will assess the safety and effectiveness of two treatments: (1) atomoxetine (also called Strattera), a nonstimulant medication for treating ADHD, and (2) parent management training (PMT), in which parents learn how to use behavioral interventions (another conventional ADHD treatment). Children will be randomly assigned to one of four treatment situations: Atomoxetine with PMT ATX without PMT Placebo (a pill without active medicine) with PMT Placebo without PMT After the 10-week trial ends, the researchers will continue to follow all participants who respond favorably to treatment for six months to examine the safety, effectiveness and tolerability of long-term treatment. Existing research on medication and behavioral treatments for children with ASD is sparse. The findings from this study will provide guidance for doctors

and parents on the best treatment options for many children with ASD who also have symptoms of ADHD.For rest of today's SAR click here:www.sarnet.org/frm/forsar.htm Today's SAR is provided through the support of paid subscription readers. - THANK YOU - $35 for 1 year - or free!www.sarnet.org Copyright Notice: The above items are copyright protected. They are for our readers' personal education or research purposes only and provided at their request. Articles may not be further reprinted or used commercially without consent from the copyright holders. To find the copyright

holders, follow the referenced website link provided at the beginning of each item. Lenny Schafer editor@... The Schafer Autism Report is a non-profit corporation Unsubscribe here: www.sarnet.org/frm/unsub2.htm_______________________________________________SARnets mailing listSARnets@...http://lists.igc.org/mailman/listinfo/sarnetsYou can unsubscribe send email:http://www.sarnet.org/frm/unsub2.htm-- You are subscribed as: deniseslist@...